Refine by
Drug Analysis And Development Suppliers In Spain
8 companies found
based inCambridge, MASSACHUSETTS (USA)
TriNetX is the global health research network that connects the world of drug discovery and development from pharmaceutical company to study site, and investigator to patient by sharing real-world data to make clinical and observational research ...
Analyze and prioritize based on the frequency, severity, and potential impact of signals to deliver the highest level of drug safety. ...
based inTorrance, CALIFORNIA (USA)
Phenomenex isn’t your typical scientific company. Founded nearly 40 years ago, Phenomenex is a global technology leader committed to developing novel analytical chemistry solutions that solve the separation and purification challenges of researchers ...
based inPontevedra, SPAIN
Zinereo aims to offer CDMO services of medicines and pharmaceutical-quality probiotics, tackling current human and animal health issues from a ground-breaking perspective. We are a dynamic company with over 80 ...
based inParis, FRANCE
The Bioprojet company was founded in 1982 under the impetus of Jeanne-Marie Lecomte and Jean-Charles Schwartz, doctors of pharmacy and sciences. From very different backgrounds, Jeanne-Marie Lecomte made her career in the pharmaceutical industry, ...
based inDerio - Bizkaia, SPAIN
We are experts in screening, drug discovery and biomolecule characterization employing tools based in our propietary microarray technology. We offer a variety full analytical services as well as development of customized tools suited to your ...
based inDerio, SPAIN
Innoprot is a company specializing in the development and provision of high-quality cell lines and assays for use in research and drug discovery. They offer a wide array of G protein-coupled receptor (GPCR) cell lines, which are essential for ...
based inSant Quintí de Mediona, SPAIN
BCN Peptides is a European GMP API manufacturing company based in Barcelona. We are a privately owned CDMO based in Barcelona, completely focused on the GMP manufacture of Bioactive Peptides for pharmaceutical, veterinary and cosmetic applications. ...
based inGeneve, SWITZERLAND
STALICLA has developed the first neurodevelopmental disorder-specific precision medicine discovery platform with an initial application in autism spectrum disorder (ASD). Until now, patient diagnosis and drug development for ASD and other NDDs have ...
STALICLA’s precision medicine approach begins with ‘endophenotyping’-identifying the nonbehavioral physical and molecular presentations of NDDs and characterizing subgroups of patients with similar disease signatures. DEPI matches ...